Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) rose 10.7% during mid-day trading on Tuesday. The company traded as high as $3.45 and last traded at $3.32. Approximately 42,819 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 56,388 shares. The stock had previously closed at $3.00.
Alpha Tau Medical Trading Down 12.8%
The business’s fifty day simple moving average is $3.71 and its 200 day simple moving average is $2.38.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is an Israeli clinical-stage medical technology company developing cancer treatments. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver radiation directly within a solid tumor.
The treatment uses small sources containing radium-224 that are placed in a tumor. As the material decays, it releases short-range alpha particles intended to damage cancer cells while limiting radiation exposure to surrounding tissue. Alpha DaRT remains investigational and is being studied for potential use in several types of cancer.
Founded in 2016, the company is based in Jerusalem and conducts clinical research in Israel and other countries, including the United States.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
